This trial is testing whether a new method for artificial insemination is safe and effective.
4 Primary · 0 Secondary · Reporting Duration: 7 weeks
Experimental Treatment
214 Total Participants · 1 Treatment Group
Primary Treatment: FemaSeed Localized Directional Insemination · No Placebo Group · N/A
Age 19 - 40 · Female Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Texas | 23.3% |
Ohio | 13.3% |
Florida | 10.0% |
Other | 53.3% |
18 - 65 | 100.0% |
University of Cincinnati Physicians | 11.1% |
Red Rock Fertility Center | 11.1% |
Center of Reproductive Medicine | 11.1% |
Other | 66.7% |
Met criteria | 89.7% |
Did not meet criteria | 10.3% |
0 | 50.0% |
2 | 25.0% |
3+ | 25.0% |